UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 13D and 13G filings for Rein Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-05 5:17 pm Sale |
2024-11-04 | 13G | Rein Therapeutics Inc. RNTX |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 960,665 4.400% |
-851,962 (-47.00%) |
Filing |
| 2024-03-05 7:14 pm Purchase |
2024-02-28 | 13G | Rein Therapeutics Inc. RNTX |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 1,812,627 6.200% |
1,812,627 (New Position) |
Filing |